Skip to main content

Matthew Shea

Stock Analyst at Needham

Total Price Targets
3
Stocks Covered
3
Sectors
Healthcare
Most Recent
Dec 12, 2025

Notable Calls (Last 12 Months)

Most Bullish

  • TOI+64.5%
    The Oncology Institute, Inc.
    $5.00 targetNov 25, 2025
  • ASTH+24.7%
    Astrana Health, Inc.
    $28.00 targetDec 12, 2025

Most Bearish

  • ASTH+24.7%
    Astrana Health, Inc.
    $28.00 targetDec 12, 2025
  • TOI+64.5%
    The Oncology Institute, Inc.
    $5.00 targetNov 25, 2025

Stocks Covered by Matthew Shea

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
ASTHAstrana Health, Inc.$28.00$34.62-19.1%1Dec 12, 2025
TOIThe Oncology Institute, Inc.$5.00$4.05+23.5%1Nov 25, 2025
PRVAPrivia Health Group, Inc.$25.00$24.76+1.0%1Jan 10, 2025

Recent Activity

  • Dec 12, 2025— Set$28.00price target onASTH(Astrana Health, Inc.)
  • Nov 25, 2025— Set$5.00price target onTOI(The Oncology Institute, Inc.)
  • Jan 10, 2025— Set$25.00price target onPRVA(Privia Health Group, Inc.)

Frequently Asked Questions

Who is Matthew Shea?

Matthew Shea is a stock analyst at Needham covering 3 stocks primarily in Healthcare. They have issued 3 price targets since Jan 10, 2025.

What stocks does Matthew Shea cover?

Matthew Shea currently covers 3 stocks, including ASTH, TOI, PRVA.

What is Matthew Shea's latest price target?

Matthew Shea's most recent price target was $28.00 on ASTH (Astrana Health, Inc.), set on Dec 12, 2025.

What is Matthew Shea's highest price target?

Matthew Shea's highest issued price target is $28.00 on ASTH, set on Dec 12, 2025.

Coverage based on publicly published price targets. Not investment advice.